Glucagonoma and pseudoglucagonoma syndromes

International Journal of Dermatology - Tập 36 Số 2 - Trang 81-89 - 1997
Robert A. Schwartz1
1Department of Dermatology, New Jersey Medical School, Newark 07103-2714, USA.

Tóm tắt

Từ khóa


Tài liệu tham khảo

10.1016/0738-081X(93)90103-J

10.1159/000420005

10.1016/S0147-0272(81)80014-1

Lawecki J, 1986, Clinical observation of 3 patients with glucagonoma, Acta Medica Polona, 27, 57

10.1097/00005792-198003000-00002

10.1016/0002-9343(87)90424-4

10.1001/archderm.114.2.224

10.1210/edrv-2-3-347

Leichter SB, 1986, The Skin in Diabetes, 143

Rappersberger K, 1987, Das glukagonom‐Syndrom, Hautarzt, 38, 589

Kasper CS, 1992, Necrolytic migratory erythema: unresolved problems in diagnosis and pathogenesis, A case report and literature review, 49, 120

10.1016/0190-9622(91)70285-A

10.1111/j.1365-2133.1990.tb04201.x

10.1016/0190-9622(91)70076-E

10.1111/j.1440-0960.1994.tb01804.x

10.1111/j.1440-0960.1994.tb01792.x

Cristancho NB, 1994, Eritema necrolítico migratorio. Un marcador de enfermedad sistémica, Revista Clínica Española, 194, 654

Boden G., 1987, Insulinoma and glucagonoma, Semin Oncol, 14, 253

Leung CB, 1992, A Chinese woman with glucagonoma syndrome, Chinese Med J, 105, 514

Schwartz RA, 1989, Clinical Dermatology, 4

Schwartz RA, 1989, Clinical Dermatology, 4

10.1007/978-1-4612-3790-7_15

10.1159/000246789

10.1007/s001050050109

10.1016/0190-9622(95)90345-3

10.1007/s001050050232

Sibrack LA, 1978, Cutaneous manifestations of pancreatic diseases, Cutis, 21, 763

Chodynicka B, 1995, Congressus Dermatologiae 1995 23‐25.06 Lódź, Prezentacja przypadków, 1

10.1111/j.1365-2133.1991.tb14773.x

Kelly CP, 1989, Necrolytic migratory erythema with elevated plasma enteroglucagon in celiac disease, Gastroenterol, 96, 1350, 10.1016/S0016-5085(89)80023-X

Goodenberger DM, 1979, Necrolytic migratory erythema without glucagonoma. Report of two cases, Arch Dermatol, 115, 1429, 10.1001/archderm.1979.04010120027012

True L, 1979, A pseudo‐glucagonoma syndrome, Clin Res, 27, 51A

True L.Letter to RA Schwartz 1988 May 6.

Doyle JA, 1979, Hyperglucagonaemia and necrolytic migratory erythema in cirrhosis—possible pseudoglucagonoma syndrome, Br J Dermatol, 100, 581

10.1159/000250159

10.1097/00000372-198212000-00002

Walker NPJ., 1982, Atypical necrolytic migratory erythema in association with a jejunal adenocarcinoma, J Roy Soc Med, 75, 134, 10.1177/014107688207500215

10.1016/S0190-9622(96)90299-6

10.1016/0190-9622(91)70236-U

10.1016/S0190-9622(08)80892-4

10.1056/NEJM198809083191003

Boden G., 1989, Insulinomas and glucagonomas, Gastroenterol Clin North Am, 18, 831, 10.1016/S0889-8553(21)00444-1

Yu R‐Y, 1992, Glucagonoma syndrome, Chinese Med J, 105, 879

10.1016/0026-0495(92)90005-U

10.1016/S0248-8663(05)82192-7

10.1111/j.1346-8138.1992.tb03241.x

10.1016/S0046-8177(79)80032-5

Bolt RJ, 1986, Glucagonoma—an underdiagnosed syndrome, West J Med, 144, 746

10.1111/j.1365-2133.1990.tb04505.x

Gorguet B, 1994, “Une dermatose.témoin”. Erythème migratoire nécrolytique pouvant entrer dans le cadre d'un syndrome du glucagonome, Ann Pathol, 14, 129

10.1111/j.1365-2230.1993.tb02253.x

Xu S‐M, 1994, Glucagonoma syndrome. Report of one case and review of the Chinese literature, Chinese J Surg, 32, 565

10.1016/S0140-6736(81)90577-8

Thivolet J, 1974, Érythéme cutané migrateur avec nécrose épidermique superficielle au cours d'une pancreatite chronique, Bull Soc Franc Dermatol Syphilol, 81, 415

Röckl H, 1977, Staphylodermia superficialis circinata. Die 5. obligate kutane paraneoplasie, Hautarzt, 28, 178

Massa MC, 1988, Necrolytic migratory erythema associated with an odontogenic infection: an example of pseudoglucagonoma syndrome, Cutis, 41, 190

10.1001/archderm.1942.01500120037004

10.1056/NEJM196606232742503

Wilkinson DS, 1973, Necrolytic migratory erythema with carcinoma of the pancreas, Trans St. Johns Dermatol Soc, 59, 244

10.1016/S0140-6736(74)91343-9

10.1056/NEJM197703102961003

10.1016/S0140-6736(76)91118-1

10.1016/0002-9343(81)90858-5

10.1016/0026-0495(87)90055-2

10.1093/ajcn/39.3.351

10.1002/1097-0142(19860215)57:4<860::AID-CNCR2820570429>3.0.CO;2-U

10.1016/S0140-6736(80)90572-3

Schmid R, 1988, Effect of somatostatin on skin lesions and concentrations of plasma amino acids in a patient with glucagonoma‐syndrome, Hepatogastroenterol, 35, 34

10.1016/S0190-9622(84)70192-7

10.1111/j.0954-6820.1985.tb08856.x

10.1097/00007611-198202000-00025

10.1016/S0046-8177(87)80416-1

Yano T, 1982, Glucagon‐secreting pancreatic islet cell carcinoma, containing insulin and somatostatin, with hypoglycemic attack, Am J Gastroenterol, 77, 387

10.1016/0167-0115(85)90205-8

10.7326/0003-4819-100-2-233

10.1056/NEJM198801143180216

10.1007/BF01605144

10.1007/BF01651010

10.1001/archinte.140.2.262

10.1097/00000441-199506000-00006

10.1016/0002-9343(75)90579-3

10.1007/BF01219741

Quencez E, 1987, Syndrome du glucagonemie a glucagonémie normale, Ann Derm Venereol (Paris), 114, 1103

10.1136/gut.25.7.784

Khandekar JD, 1987, Response of glucagonoma syndrome to lomustine, Cancer Treat Rep, 70, 433

10.1097/00000478-198607000-00001

Poiares Baptista A, 1987, Syndrome du glucagonome. Image histologique inhabituelle, Ann Dermatol Venereol (Paris), 114, 55

10.1111/j.1365-2559.1986.tb02468.x

10.1016/0168-8227(94)90160-0

Schmid KW, 1945, Expression of chromogranin A and B and secretoneurin immuno‐reactivity in neoplastic and nonneoplastic pancreatic alpha cells, Virchows Arciv, 425, 127

10.1159/000180312

Lax E, 1986, Neglected radiologic signs of the glucagonoma syndrome, Diagn Imag Clin Med, 55, 321

10.1148/radiology.150.2.6318260

10.1016/S0190-9622(85)70133-8

10.1111/j.1346-8138.1987.tb03613.x

Chorzelski TP, 1995, Congressus Dermatologiae 23‐23.06.1995 Lódź. Prezentacja przypadków, 22

Darmstadt GL, 1992, Dermatitis as a presenting sign of cystic fibrosis, Arch Dermatol, 128, 1358, 10.1001/archderm.1992.01680200068009

10.1007/BF00371650

10.1016/S0190-9622(83)70113-1

10.7326/0003-4819-108-1-64

10.3949/ccjm.52.1.81

10.1016/S0190-9622(87)70063-2

10.1056/NEJM199202203260804

Modlin IM, 1993, Management of unresectable malignant endocrine tumors of the pancreas, Surg Gynecol Obstet, 176, 507

10.1056/NEJM198606263142606

10.7326/0003-4819-107-2-162

10.1159/000201211

10.1111/j.1365-2265.1989.tb00436.x

10.1111/j.1749-6632.1994.tb17300.x

10.1097/00004836-199010000-00009

10.1002/bjs.1800760311

Makowka L, 1989, Transplantation of the liver for metastatic endocrine tumors of the intestine of the intestine and pancreas, Surg Gynecol Obstet, 168, 107

Mercadal M, 1993, Anestesia en un caso de glucagonoma, Rev Esp Anestesiol Reaim, 40, 153

10.1016/0002-9343(87)90456-6

10.1097/00000421-199006000-00019

10.1007/BF03348803

10.7326/0003-4819-108-3-340

Eriksson B, 1987, Treatment of malignant endocrine pancreatic tumors with human leukocyte interferon, Cancer Treat Rep, 71, 31

10.1001/archderm.129.2.246